QIM
IMMU

Quantitative Investment Management’s Immunomedics Inc IMMU Stock Holding History

Quantitative Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-70,531
Closed -$1.49M – 898
2019
Q4 		$1.49M Sell
70,531
-8,683
-11% -$153K 0.05% 377
2019
Q3 		$1.05M Buy
+79,214
New +$1.16M 0.06% 339
2018
Q3 		– Sell
-44,500
Closed -$1.05M – 969
2018
Q2 		$1.05M Buy
+44,500
New +$894K 0.02% 488
2017
Q4 		– Sell
-25,200
Closed -$352K – 926
2017
Q3 		$352K Buy
+25,200
New +$251K ﹤0.01% 631

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantitative Investment Management's IMMU Position: Q1 2020 in Review

Quantitative Investment Management sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 70,531 shares — an estimated $1.49M sold.

Quantitative Investment Management first reported a position in IMMU in Q3 2017 and held it in 4 quarters. The position peaked at $1.49M in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Quantitative Investment Management reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 70,531 Immunomedics Inc shares in Q1 2020, an estimated $1.49M.
  • Quantitative Investment Management first reported a position in Immunomedics Inc in Q3 2017 and held it in 4 quarters.
  • Quantitative Investment Management's Immunomedics Inc position peaked at $1.49M in Q4 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Quantitative Investment Management's 13F filing for Q1 2020, filed 15 May 2020.